[Castleman B, Iverson L, Menendez VP. Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer 1956; 9: 822-30.10.1002/1097-0142(195607/08)9:4<822::AID-CNCR2820090430>3.0.CO;2-4]Search in Google Scholar
[Gaba AR, Stein RS, Sweet DL, Variakojis D. Multicentric giant lymph node hyperplasia. Am J Clin Pathol 1978; 69: 86-90.10.1093/ajcp/69.1.86]Search in Google Scholar
[Soulier J, Grollet L, Oksenhendler E, Miclea JM, Cacoub P, Baruchel A, et al. Molecular analysis of clonality in Castleman's disease. Blood 1995; 86: 1131-8.10.1182/blood.V86.3.1131.1131]Search in Google Scholar
[Soulier J, Grollet L, Oksenhendler E, Cacoub P, Cazals-Hatem D, Babinet P, et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 1995; 86: 1276-80.10.1182/blood.V86.4.1276.bloodjournal8641276]Search in Google Scholar
[Gessain A, Sudaka A, Brière J, Fouchard N, Nicola MA, Rio B, et al. Kaposi sarcoma-associated herpes-like virus (human herpesvirus type 8) DNA sequences in multicentric Castleman's disease: is there any relevant association in non-human immunodeficiency virus-infected patients? Blood 1996; 87: 414-6.10.1182/blood.V87.1.414.414]Search in Google Scholar
[Herrada J, Cabanillas F, Rice L, Manning J, Pugh W. The clinical behavior of localized and multicentric Castleman disease. Ann Intern Med 1998; 128: 657-62.10.7326/0003-4819-128-8-199804150-00010]Search in Google Scholar
[Casper C. The aetiology and management of Castleman disease at 50 years: translating pathophysiology to patient care. Br J Haematol 2005; 129: 3-17.10.1111/j.1365-2141.2004.05311.x]Search in Google Scholar
[Seco JL, Velasco F, Manuel JS, Serrano SR, Tomas L, Velasco A. Retroperitoneal Castleman's disease. Surgery 1992; 112: 850-5.]Search in Google Scholar
[McCarty MJ, Vukelja SJ, Banks PM, Weiss RB. Angiofollicular lymph node hyperplasia (Castleman's disease). Cancer Treat Rev 1995; 21: 291-310.10.1016/0305-7372(95)90034-9]Search in Google Scholar
[Shahidi H, Myers JL, Kvale PA. Castleman's disease. Mayo Clin Proc 1995; 70: 969-77.10.4065/70.10.969]Search in Google Scholar
[Neuhof D, Debus J. Outcome and late complications of radiotherapy in patients with unicentric Castleman disease. Acta Oncol 2006; 45: 1126-31.10.1080/02841860600812701]Search in Google Scholar
[Chronowski GM, Ha CS, Wilder RB, Cabanillas F, Manning J, Cox JD. Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy. Cancer 2001; 92: 670-6.10.1002/1097-0142(20010801)92:3<670::AID-CNCR1369>3.0.CO;2-Q]Search in Google Scholar
[Bowne WB, Lewis JJ, Filippa DA, Niesvizky R, Brooks AD, Burt ME, et al. The management of unicentric and multicentric Castleman's disease: a report of 16 cases and a review of the literature. Cancer 1999; 85: 706-17.10.1002/(SICI)1097-0142(19990201)85:3<706::AID-CNCR21>3.0.CO;2-7]Search in Google Scholar
[de Vries IA, van Acht MM, Demeyere TB, Lybeert ML, de Zoete JP, Nieuwenhuijzen GA. Neoadjuvant radiotherapy of primary irresectable unicentric Castleman's disease: a case report and review of the literature. Radiat Oncol 2010; 5: 7.10.1186/1748-717X-5-7]Search in Google Scholar
[Peterson BA, Frizzera G. Multicentric Castleman's disease. Semin Oncol 1993; 20: 636-47.]Search in Google Scholar
[Keller AR, Hochholzer L, Castleman B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer 1972; 29: 670-83.10.1002/1097-0142(197203)29:3<670::AID-CNCR2820290321>3.0.CO;2-#]Search in Google Scholar
[Ye B, Gao SG, Li W, Yang LH, Zhao SH, Ma K, et al. A retrospective study of unicentric and multicentric Castleman's disease: a report of 52 patients. Med Oncol 2010; 27: 1171-8.10.1007/s12032-009-9355-0]Search in Google Scholar
[Lin CY, Chang YL. Castleman's disease in the head and neck region: Meta-analysis of reported cases in Taiwan and literature review. J Formos Med Assoc 2010; 109: 913-20.10.1016/S0929-6646(10)60139-8]Search in Google Scholar
[Paumier A, Ghalibafian M, Beaudre A, Ferreira I, Pichenot C, Messai T, et al. Involved-node radiotherapy and modern radiation treatment techniques in patients with Hodgkin lymphoma. Int J Radiat Oncol Biol Phys 2011; 80: 199-205.10.1016/j.ijrobp.2010.09.007]Search in Google Scholar
[Welsh J, Gomez D, Palmer MB, Riley BA, Mayankkumar AV, Komaki R, Dong L, et al. Intensity-modulated proton therapy further reduces normal tissue exposure during definitive therapy for locally advanced distal esophageal tumors: A dosimetric study. Int J Radiat Oncol Biol Phys 2011; 81: 1336-42.10.1016/j.ijrobp.2010.07.2001]Search in Google Scholar
[Lievens Y, Nulens A, Gaber MA, Defraene G, De Wever W, Stroobants S, et al. Intensity-modulated radiotherapy for locally advanced non-small-cell lung cancer: a dose-escalation planning study. Int J Radiat Oncol Biol Phys 2011; 80: 306-13.10.1016/j.ijrobp.2010.06.025]Search in Google Scholar
[Banu A, Enis O, Kaan G, Gungor G. Intensity modulated radiotherapy (IMRT) in bilateral retinoblastoma. Radiol Oncol 2010; 44: 194-8.]Search in Google Scholar
[Bailey DW, Lalith K; Podgorsak MB. A fully electronic intensity-modulated radiation therapy quality assurance (IMRT) process implemented in a network comprised of independent treatment planning, record and verify, and delivery systems. Radiol Oncol 2010; 44: 124-30.]Search in Google Scholar
[Śladowska A, Hetnał M, Dymek P, Kabat D, Kisielewicz K, Wawrzak M, et al. Application of IMRT in adjuvant treatment of soft tissue sarcomas of the thigh - preliminary results. Reports of Practical Oncology and Radiotherapy 2011; 16: 110-4.10.1016/j.rpor.2011.02.006]Search in Google Scholar
[Weisenburger DD, DeGowin RL, Gibson P, Armitage JO. Remission of giant lymph node hyperplasia with anemia after radiotherapy. Cancer 1979; 44: 457-62.10.1002/1097-0142(197908)44:2<457::AID-CNCR2820440212>3.0.CO;2-4]Search in Google Scholar
[Nordstrom DG, Tewfik HH, Latourette HB. Plasma cell giant lymph node hyperplasia responding to radiation therapy. AJR Am J Roentgenol 1978; 130: 169-71.10.2214/ajr.130.1.169]Search in Google Scholar
[Marti S, Pahissa A, Guardia J, Moragas A, Bacardi R. Multicentric giant follicular lymph node hyperplasia. Favorable response to radiotherapy. Cancer 1983; 51: 808-10.10.1002/1097-0142(19830301)51:5<808::AID-CNCR2820510510>3.0.CO;2-5]Search in Google Scholar
[Veldhuis GJ, van der Leest AH, de Wolf JT, de Vries EG, Vellenga E. A case of localized Castleman's disease with systemic involvement: treatment and pathogenetic aspects. Ann Hematol 1996; 73: 47-50.10.1007/s002770050201]Search in Google Scholar
[Beck JT, Hsu SM, Wijdenes J, Bataille R, Klein B, Vesole D, et al. Brief report: alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukin-6 antibody. N Engl J Med 1994; 330: 602-5.10.1056/NEJM199403033300904]Search in Google Scholar
[Li X, Wang X, Li Y, Zhang X. A 4D IMRT planning method using deformable image registration to improve normal tissue sparing with contemporary delivery techniques. Radiat Oncol 2011; 6: 83.10.1186/1748-717X-6-83]Search in Google Scholar
[Chapet O, Fraass BA, Ten Haken RK. Multiple fields may offer better esophagus sparing without increased probability of lung toxicity in optimized IMRT of lung tumors. Int J Radiat Oncol Biol Phys 2006; 65: 255-65.10.1016/j.ijrobp.2005.12.028]Search in Google Scholar
[Suciu D. Cellular death by apoptosis in some radiosensitive and radioresistant mammalian tissues. J Theor Biol 1983; 105: 391-401.10.1016/0022-5193(83)90183-2]Search in Google Scholar